Novo Nordisk's data exclusivity on semaglutide expired January 4, 2026 , and the key Canadian patent has lapsed
Dehydration risk is also higher in older adults, which amplifies the kidney safety advantage of tirzepatide (lower AKI reporting rate)
Some early research points to benefits, but long-term effects are unclear
The Precision Peptide Genetic Test may help provide context about your predisposition in peptide signaling pathwaysvariants in GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313which can support a more informed conversation with your provider about medication choice and expected dosing needs
Risks of all-cause and suicide mortality in mental disorders: a meta-review
Your healthcare team can adjust your treatment plan, provide supportive management for side effects, or consider alternative therapies if GLP-1 receptor agonists are not suitable for you